This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Spotts, G. D.
Right arrow Articles by Hann, S. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Spotts, G. D.
Right arrow Articles by Hann, S. R.

 Previous Article  |  Next Article 

Mol. Cell. Biol., Mar 1997, 1459-1468, Vol 17, No. 3
Copyright © 1997, American Society for Microbiology

Identification of downstream-initiated c-Myc proteins which are dominant-negative inhibitors of transactivation by full-length c-Myc proteins

GD Spotts, SV Patel, Q Xiao and SR Hann
Department of Cell Biology, Vanderbilt University School of Medicine, Nashville, Tennessee 37232-2175, USA.

The c-myc gene has been implicated in multiple cellular processes including proliferation, differentiation, and apoptosis. In addition to the full-length c-Myc 1 and 2 proteins, we have found that human, murine, and avian cells express smaller c-Myc proteins arising from translational initiation at conserved downstream AUG codons. These c- Myc short (c-Myc S) proteins lack most of the N-terminal transactivation domain but retain the C-terminal protein dimerization and DNA binding domains. As with full-length c-Myc proteins, the c-Myc S proteins appear to be localized to the nucleus, are relatively unstable, and are phosphorylated. Significant levels of c-Myc S, often approaching the levels of full-length c-Myc, are transiently observed during the rapid growth phase of several different types of cells. Optimization of the upstream initiation codons resulted in greatly reduced synthesis of the c-Myc S proteins, suggesting that a "leaky scanning" mechanism leads to the translation of these proteins. In some hematopoietic tumor cell lines having altered c-myc genes, the c-Myc S proteins are constitutively expressed at levels equivalent to that of full-length c-Myc. As predicted, the c-Myc S proteins are unable to activate transcription and inhibited transactivation by full-length c- Myc proteins, suggesting a dominant-negative inhibitory function. While these transcriptional inhibitors would not be expected to function as full-length c-Myc, the occurrence of tumors which express constitutive high levels of c-Myc S and their transient synthesis during rapid cell growth suggest that these proteins do not interfere with the growth- promoting functions of full-length c-Myc.


This article has been cited by other articles:

  • Liu, X., Vorontchikhina, M., Wang, Y.-L., Faiola, F., Martinez, E. (2008). STAGA Recruits Mediator to the MYC Oncoprotein To Stimulate Transcription and Cell Proliferation. Mol. Cell. Biol. 28: 108-121 [Abstract] [Full Text]  
  • Cheng, T.-H., Cohen, S. N. (2007). Human MDM2 Isoforms Translated Differentially on Constitutive versus p53-Regulated Transcripts Have Distinct Functions in the p53/MDM2 and TSG101/MDM2 Feedback Control Loops. Mol. Cell. Biol. 27: 111-119 [Abstract] [Full Text]  
  • Sanders, J. A., Gruppuso, P. A. (2006). Coordinated regulation of c-Myc and Max in rat liver development. Am. J. Physiol. Gastrointest. Liver Physiol. 290: G145-G155 [Abstract] [Full Text]  
  • Benassayag, C., Montero, L., Colombie, N., Gallant, P., Cribbs, D., Morello, D. (2005). Human c-Myc Isoforms Differentially Regulate Cell Growth and Apoptosis in Drosophila melanogaster. Mol. Cell. Biol. 25: 9897-9909 [Abstract] [Full Text]  
  • Murakami, Y., Siripanyaphinyo, U., Hong, Y., Tashima, Y., Maeda, Y., Kinoshita, T. (2005). The Initial Enzyme for Glycosylphosphatidylinositol Biosynthesis Requires PIG-Y, a Seventh Component. Mol. Biol. Cell 16: 5236-5246 [Abstract] [Full Text]  
  • Mukherjee, S., Conrad, S. E. (2005). c-Myc Suppresses p21WAF1/CIP1 Expression during Estrogen Signaling and Antiestrogen Resistance in Human Breast Cancer Cells. J. Biol. Chem. 280: 17617-17625 [Abstract] [Full Text]  
  • Alarcon-Vargas, D., Ronai, Z.'e. (2004). c-Jun-NH2 Kinase (JNK) Contributes to the Regulation of c-Myc Protein Stability. J. Biol. Chem. 279: 5008-5016 [Abstract] [Full Text]  
  • Qu, L., Huang, S., Baltzis, D., Rivas-Estilla, A.-M., Pluquet, O., Hatzoglou, M., Koumenis, C., Taya, Y., Yoshimura, A., Koromilas, A. E. (2004). Endoplasmic reticulum stress induces p53 cytoplasmic localization and prevents p53-dependent apoptosis by a pathway involving glycogen synthase kinase-3{beta}. Genes Dev. 18: 261-277 [Abstract] [Full Text]  
  • Gregory, M. A., Qi, Y., Hann, S. R. (2003). Phosphorylation by Glycogen Synthase Kinase-3 Controls c-Myc Proteolysis and Subnuclear Localization. J. Biol. Chem. 278: 51606-51612 [Abstract] [Full Text]  
  • Ulanet, D. B., Torbenson, M., Dang, C. V., Casciola-Rosen, L., Rosen, A. (2003). Unique conformation of cancer autoantigen B23 in hepatoma: A mechanism for specificity in the autoimmune response. Proc. Natl. Acad. Sci. USA 100: 12361-12366 [Abstract] [Full Text]  
  • Liu, X., Tesfai, J., Evrard, Y. A., Dent, S. Y. R., Martinez, E. (2003). c-Myc Transformation Domain Recruits the Human STAGA Complex and Requires TRRAP and GCN5 Acetylase Activity for Transcription Activation. J. Biol. Chem. 278: 20405-20412 [Abstract] [Full Text]  
  • Jensen, N. A., Pedersen, K. M., Lihme, F., Rask, L., Nielsen, J. V., Rasmussen, T. E., Mitchelmore, C. (2003). Astroglial c-Myc Overexpression Predisposes Mice to Primary Malignant Gliomas. J. Biol. Chem. 278: 8300-8308 [Abstract] [Full Text]  
  • Oritani, K., Hirota, S., Nakagawa, T., Takahashi, I., Kawamoto, S.-i., Yamada, M., Ishida, N., Kadoya, T., Tomiyama, Y., Kincade, P. W., Matsuzawa, Y. (2003). T lymphocytes constitutively produce an interferonlike cytokine limitin characterized as a heat- and acid-stable and heparin-binding glycoprotein. Blood 101: 178-185 [Abstract] [Full Text]  
  • Mu, Z. M., Yin, X. Y., Prochownik, E. V. (2002). Pag, a Putative Tumor Suppressor, Interacts with the Myc Box II Domain of c-Myc and Selectively Alters Its Biological Function and Target Gene Expression. J. Biol. Chem. 277: 43175-43184 [Abstract] [Full Text]  
  • Sheen, J.-H., Dickson, R. B. (2002). Overexpression of c-Myc Alters G1/S Arrest following Ionizing Radiation. Mol. Cell. Biol. 22: 1819-1833 [Abstract] [Full Text]  
  • Schneider, R., Kozak, M. (2001). New Ways of Initiating Translation in Eukaryotes?. Mol. Cell. Biol. 21: 8238-8246 [Full Text]  
  • Yudt, M. R., Cidlowski, J. A. (2001). Molecular Identification and Characterization of A and B Forms of the Glucocorticoid Receptor. Mol. Endocrinol. 15: 1093-1103 [Abstract] [Full Text]  
  • Bardeesy, N., Bastian, B. C., Hezel, A., Pinkel, D., DePinho, R. A., Chin, L. (2001). Dual Inactivation of RB and p53 Pathways in RAS-Induced Melanomas. Mol. Cell. Biol. 21: 2144-2153 [Abstract] [Full Text]  
  • Claassen, G. F., Hann, S. R. (2000). A role for transcriptional repression of p21CIP1 by c-Myc in overcoming transforming growth factor beta -induced cell-cycle arrest. Proc. Natl. Acad. Sci. USA 10.1073/pnas.150006697v1 [Abstract] [Full Text]  
  • Niklinski, J., Claassen, G., Meyers, C., Gregory, M. A., Allegra, C. J., Kaye, F. J., Hann, S. R., Zajac-Kaye, M. (2000). Disruption of Myc-Tubulin Interaction by Hyperphosphorylation of c-Myc during Mitosis or by Constitutive Hyperphosphorylation of Mutant c-Myc in Burkitt's Lymphoma. Mol. Cell. Biol. 20: 5276-5284 [Abstract] [Full Text]  
  • McGuffie, E. M., Pacheco, D., Carbone, G. M. R., Catapano, C. V. (2000). Antigene and Antiproliferative Effects of a c-myc-targeting Phosphorothioate Triple Helix-forming Oligonucleotide in Human Leukemia Cells. Cancer Res. 60: 3790-3799 [Abstract] [Full Text]  
  • Chang, D. W., Claassen, G. F., Hann, S. R., Cole, M. D. (2000). The c-Myc Transactivation Domain Is a Direct Modulator of Apoptotic versus Proliferative Signals. Mol. Cell. Biol. 20: 4309-4319 [Abstract] [Full Text]  
  • Gregory, M. A., Hann, S. R. (2000). c-Myc Proteolysis by the Ubiquitin-Proteasome Pathway: Stabilization of c-Myc in Burkitt's Lymphoma Cells. Mol. Cell. Biol. 20: 2423-2435 [Abstract] [Full Text]  
  • Greasley, P. J., Bonnard, C., Amati, B. (2000). Myc induces the nucleolin and BN51 genes: possible implications in ribosome biogenesis. Nucleic Acids Res 28: 446-453 [Abstract] [Full Text]  
  • Sun, Y., Clark, E. A. (1999). Expression of the c-myc Proto-oncogene Is Essential for HIV-1 Infection in Activated T Cells. JEM 189: 1391-1398 [Abstract] [Full Text]  
  • Teng, B.-B., Ochsner, S., Zhang, Q., Soman, K. V., Lau, P. P., Chan, L. (1999). Mutational analysis of apolipoprotein B mRNA editing enzyme (APOBEC1): structure–function relationships of RNA editing and dimerization. J. Lipid Res. 40: 623-635 [Abstract] [Full Text]  
  • Dang, C. V. (1999). c-Myc Target Genes Involved in Cell Growth, Apoptosis, and Metabolism. Mol. Cell. Biol. 19: 1-11 [Full Text]  
  • Xiao, Q., Claassen, G., Shi, J., Adachi, S., Sedivy, J., Hann, S. R. (1998). Transactivation-defective c-MycS retains the ability to regulate proliferation and apoptosis. Genes Dev. 12: 3803-3808 [Abstract] [Full Text]  
  • Flinn, E. M., Busch, C. M. C., Wright, A. P. H. (1998). myc Boxes, Which Are Conserved in myc Family Proteins, Are Signals for Protein Degradation via the Proteasome. Mol. Cell. Biol. 18: 5961-5969 [Abstract] [Full Text]  
  • Facchini, L., Penn, L. Z. (1998). The molecular role of Myc in growth and transformation: recent discoveries lead to new insights. FASEB J. 12: 633-651 [Abstract] [Full Text]  
  • Gandarillas, A., Watt, F. M. (1997). c-Myc promotes differentiation of human epidermal stem cells. Genes Dev. 11: 2869-2882 [Abstract] [Full Text]  
  • Anastasiadis, P. Z., Jiang, H., Bezin, L., Kuhn, D. M., Levine, R. A. (2001). Tetrahydrobiopterin Enhances Apoptotic PC12 Cell Death following Withdrawal of Trophic Support. J. Biol. Chem. 276: 9050-9058 [Abstract] [Full Text]  
  • Tailor, C. S., Marin, M., Nouri, A., Kavanaugh, M. P., Kabat, D. (2001). Truncated Forms of the Dual Function Human ASCT2 Neutral Amino Acid Transporter/Retroviral Receptor Are Translationally Initiated at Multiple Alternative CUG and GUG Codons. J. Biol. Chem. 276: 27221-27230 [Abstract] [Full Text]  
  • Claassen, G. F., Hann, S. R. (2000). A role for transcriptional repression of p21CIP1 by c-Myc in overcoming transforming growth factor beta -induced cell-cycle arrest. Proc. Natl. Acad. Sci. USA 97: 9498-9503 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»